A combination of clinical Doppler ultrasound and angiogenic biomarker assessment is currently the best approach for the evaluation of periviable fetal growth restriction

BJOG. 2023 May;130(6):687-688. doi: 10.1111/1471-0528.17352. Epub 2022 Dec 8.

Authors

Lionel Carbillon^{1

2

3}, Amelie Benbara¹, Marion Fermaut¹

Affiliations

¹ Hôpital Jean Verdier, Assistance Publique - Hôpitaux de Paris, Bondy, France.
² Université Sorbonne Paris Nord, Bobigny, France.
³ FHU I2D2 Early Identification of Individual Trajectories in NeuroDevelopemental Disorders, Paris, France.

PMID: 36482166
DOI: 10.1111/1471-0528.17352

No abstract available

Publication types

Letter
Comment

MeSH terms

Biomarkers
Female
Fetal Growth Retardation* / diagnostic imaging
Humans
Pregnancy
Ultrasonography
Ultrasonography, Doppler*
Ultrasonography, Prenatal
Umbilical Arteries / diagnostic imaging

Substances

Biomarkers